U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900712) titled 'Positive Processes and Transition to Health - Single-Session (PATH-SS)' on March 11. Brie... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06899503) titled 'Creating Linked Inpatient CGM for Kids' on March 21. Brief Summary: Continuous glucose mo... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06899555) titled 'REgistry of Paclitaxel Coated Drug Eluting Balloon in All Comers PaTients' on March 21. B... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900023) titled 'The BEACON Trial: Diagnostic Tools for Breast Lymphedema After Treatment for Breast Cancer... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900114) titled 'Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Co... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06899581) titled 'Gut Health in Children With Cancer' on March 21. Brief Summary: The purpose of this study... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900010) titled 'A Study to Evaluate CM336 in Adults with Autoimmune Bullous Disease' on March 23. Brief S... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06901414) titled 'Birth Complications and Intrauterine Constraints in the Etiology of Congenital Muscular To... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900855) titled 'Patients Seeking a Visual Impairment Certificate' on March 22. Brief Summary: This study ... Read More
U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900595) titled 'Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemipl... Read More